Valuation: Dr. Martens plc

Market Cap 64Cr 86Cr 75Cr 71Cr 119.8Cr 8.2TCr 120.39Cr 840.67Cr 325.06Cr 4.17TCr 321.64Cr 314.48Cr 13TCr P/E 2027 *
13.6x
P/E 2028 * 10.9x
Enterprise Value 84Cr 111.88Cr 97Cr 92Cr 156.54Cr 11TCr 157.31Cr 1.1TCr 424.76Cr 5.45TCr 420.28Cr 410.93Cr 17TCr EV / Sales 2027 *
1.07x
EV / Sales 2028 * 0.98x
Free-Float
57.57%
Yield 2027 *
3.73%
Yield 2028 * 3.79%
1 day-9.58%
1 month-10.33%
3 months+11.86%
6 months+30.72%
Current year+5.34%
1 month 1.08
Extreme 1.085
1.08
Current year 0.81
Extreme 0.8143
1.21
1 year 0.81
Extreme 0.8143
1.36
3 years 0.62
Extreme 0.618
1.84
5 years 0.62
Extreme 0.618
5.88
10 years 0.62
Extreme 0.618
7.25
Manager TitleAgeSince
Chief Executive Officer 55 06/01/2025
Director of Finance/CFO 53 13/05/2024
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 53 01/01/2021
Director/Board Member 55 10/07/2025
Director/Board Member 52 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-9.58%-.--% - - 86Cr
+2.24%-0.21%-32.84%-8.53% 1.09TCr
+6.59%+13.02%+52.72%+39.79% 589.72Cr
-4.68%-2.20%-41.53%-37.81% 556.13Cr
+2.40%+1.56%-31.70% - 554.48Cr
-3.04%-8.26%-8.12%+24.72% 255.59Cr
+1.22%+2.90%-12.68%-16.22% 229.05Cr
+0.26%+0.26%-36.90%+129.42% 158.72Cr
-3.17%-3.32%+27.59%+53.41% 147.72Cr
+1.03%-4.22%-30.42% - 115.71Cr
Average -1.41%+0.86%-12.65%+26.40% 410.29Cr
Weighted average by Cap. -0.25%+1.59%-15.03%+8.01%

Financials

2027 *2028 *
Net sales 78Cr 104.63Cr 91Cr 86Cr 146.39Cr 10TCr 147.12Cr 1.03TCr 397.23Cr 5.09TCr 393.04Cr 384.3Cr 16TCr 82Cr 109.73Cr 96Cr 90Cr 153.53Cr 11TCr 154.29Cr 1.08TCr 416.59Cr 5.34TCr 412.2Cr 403.03Cr 17TCr
Net income 4.85Cr 6.48Cr 5.64Cr 5.34Cr 9.07Cr 620.6Cr 9.11Cr 64Cr 25Cr 315.39Cr 24Cr 24Cr 1.01TCr 6.02Cr 8.03Cr 7Cr 6.62Cr 11Cr 769.46Cr 11Cr 79Cr 31Cr 391.05Cr 30Cr 30Cr 1.25TCr
Net Debt 20Cr 26Cr 23Cr 22Cr 37Cr 2.51TCr 37Cr 257.83Cr 100Cr 1.28TCr 99Cr 96Cr 4.09TCr 16Cr 22Cr 19Cr 18Cr 31Cr 2.11TCr 31Cr 216.26Cr 84Cr 1.07TCr 83Cr 81Cr 3.43TCr
Logo Dr. Martens plc
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company's segments include Europe, the Middle East and Africa (EMEA); Americas; and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
Employees
2,377
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
0.6700GBP
Average target price
0.9850GBP
Spread / Average Target
+47.01%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!